Literature DB >> 30059646

Fuchs' Uveitis in Iranian Patients: A Review of 89 Eyes.

Mohammad Zarei1, Sahel Darabeigi1, Mohammad Mehrpour1, Ramak Roohipoor1, Hamed Ghassemi1, Nazanin Ebrahimiadib1.   

Abstract

Purpose: To describe clinical and imaging features of Fuchs' Uveitis (FU) and investigate the rate of misdiagnosis in Iranian patients.
Methods: Records of 82 FU patients (89 eyes) were reviewed retrospectively.
Results: Remarkable findings included iris heterochromia in 14 (17.1%) patients and Fuchs' keratic precipitates in 97.8%, vitritis in 89.7% and cataract in 69.7% eyes. FU discovered as an incidental finding in 7 patients (10.0%). Imaging revealed disc hyperfluorescence, mild vascular leakage and epiretinal membrane in 72.7%, 32.5% and 19.4% of eyes, respectively. The rate of misdiagnosis was 19.5% (16 patients) with intermediate uveitis being as the most common erroneous diagnosis (10 patients). Patients with the wrong diagnosis were significantly younger (p = 0.045) and more likely to have bilateral involvement (p = 0.004) or no anterior chamber cells (p = 0.039). Conclusions: Heterochromia is an infrequent clinical feature in Iranian FU patients, however, vitreous involvement is common. Intermediate uveitis is a usual misdiagnosis.

Entities:  

Keywords:  Fuchs’ uveitis; Iranian; heterochromia; intermediate uveitis; misdiagnosis

Mesh:

Year:  2018        PMID: 30059646     DOI: 10.1080/09273948.2018.1500612

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  2 in total

1.  Using anterior segment optical coherence tomography to compare the smoothness of anterior iris surface between two eyes in unilateral Fuchs' uveitis syndrome.

Authors:  Mohammad Zarei; Nazanin Ebrahimiadib; Hamid Riazi-Esfahani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-11-03       Impact factor: 3.117

2.  Anterior segment structures in dark iris Chinese patients with unilateral Fuchs' uveitis syndrome.

Authors:  Yajing Cai; Wenjie Wu; Yingbin Wang; Suzhen Xiao; Yue Huang
Journal:  Int Ophthalmol       Date:  2022-04-02       Impact factor: 2.029

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.